Chemoinformaics analysis of Linalool-Oxide-Furanoid
| Molecular Weight | 716.421 | nRot | 9 |
| Heavy Atom Molecular Weight | 692.229 | nRig | 16 |
| Exact Molecular Weight | 716.113 | nRing | 2 |
| Solubility: LogS | -4.938 | nHRing | 2 |
| Solubility: LogP | 4.728 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 0 |
| nHetero | 23 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 71.589 |
| nHD | 0 | BPOL | 53.057 |
| QED | 0.148 |
| Synth | 5.194 |
| Natural Product Likeliness | 1.33 |
| NR-PPAR-gamma | 0.181 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.005 |
| HIA | 0.091 |
| CACO-2 | -4.815 |
| MDCK | 0.0000166 |
| BBB | 0.615 |
| PPB | 0.974668 |
| VDSS | 0.969 |
| FU | 0.0178175 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.128 |
| CYP2c19-inh | 0.054 |
| CYP2c19-sub | 0.138 |
| CYP2c9-inh | 0.04 |
| CYP2c9-sub | 0.016 |
| CYP2d6-inh | 0.865 |
| CYP2d6-sub | 0.102 |
| CYP3a4-inh | 0.898 |
| CYP3a4-sub | 0.351 |
| CL | 2.377 |
| T12 | 0.002 |
| hERG | 0.02 |
| Ames | 0.192 |
| ROA | 0.897 |
| SkinSen | 0.33 |
| Carcinogencity | 0.561 |
| EI | 0.044 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.58 |
| Antiviral | Yes |
| Prediction | 0.764251 |